-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Haemonetics, Raises Price Target to $70

Benzinga·05/28/2026 20:02:43
Listen to the news
Citigroup analyst Joanne Wuensch maintains Haemonetics (NYSE:HAE) with a Neutral and raises the price target from $64 to $70.